Disease diversity and FLT3 mutations

被引：5
|
作者：
Smith, Catherine Choy [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 52期
关键词：
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; GASTROINTESTINAL STROMAL TUMORS; KINASE DOMAIN MUTATIONS; THERAPEUTIC TARGET; ITD MUTATIONS; RESISTANCE; VALIDATION; ACTIVATION; GEFITINIB;
D O I：
10.1073/pnas.1320579110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：20860 / 20861
页数：2
相关论文
共 50 条
  • [41] Discovery of the selective and efficacious inhibitors of FLT3 mutations
    Zhi, Yanle
    Li, Baoquan
    Yao, Chao
    Li, Hongmei
    Chen, Puzhou
    Bao, Jiyin
    Qin, Tianren
    Wang, Yue
    Lu, Tao
    Lu, Shuai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 303 - 315
  • [42] Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia
    Williams, Allen B.
    Li, Li
    Bao Nguyen
    Brown, Patrick
    Levis, Mark
    Small, Donald
    BLOOD, 2012, 120 (15) : 3069 - 3079
  • [43] Myeloid/lymphoid neoplasms with FLT3 rearrangement
    Tang, Guilin
    Tam, Wayne
    Short, Nicholas J.
    Bose, Prithviraj
    Wu, David
    Hurwitz, Stephanie N.
    Bagg, Adam
    Rogers, Heesun J.
    Hsi, Eric D.
    Quesada, Andres E.
    Wang, Wei
    Miranda, Roberto N.
    Bueso-Ramos, Carlos E.
    Medeiros, L. Jeffrey
    Nardi, Valentina
    Hasserjian, Robert P.
    Arber, Daniel A.
    Orazi, Attilio
    Foucar, Kathryn
    Wang, Sa A.
    MODERN PATHOLOGY, 2021, 34 (09) : 1673 - 1685
  • [44] FLT3 Inhibitors in AML: Are We There Yet?
    Sudhindra, Akshay
    Smith, Catherine Choy
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (02) : 174 - 185
  • [45] RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias
    Usher, Suzanne G.
    Radford, Alan D.
    Villiers, Elizabeth J.
    Blackwood, Laura
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (01) : 65 - 77
  • [46] Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia
    Alkhayat, Nawaf
    Elborai, Yasser
    Al Sharif, Omer
    Al Shahrani, Mohammad
    Alsuhaibani, Omar
    Awad, Mohammed
    Elghezal, Hatem
    Bouhajar, Inesse Ben-abdallah
    Alfaraj, Mona
    Al Mussaed, Eman
    Alabbas, Fahad
    Elyamany, Ghaleb
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2017, 11
  • [47] Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors
    Williams, A. B.
    Nguyen, B.
    Li, L.
    Brown, P.
    Levis, M.
    Leahy, D.
    Small, D.
    LEUKEMIA, 2013, 27 (01) : 48 - 55
  • [48] The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms
    Ferng, Timothy T.
    Terada, Daisuke
    Ando, Makoto
    Tarver, Theodore C.
    Chaudhary, Fihr
    Lin, Kimberly C.
    Logan, Aaron C.
    Smith, Catherine C.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (05) : 844 - 854
  • [49] FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?
    Levis, Mark
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 220 - 226
  • [50] Detection of KIT and FLT3 Mutations in Acute Myeloid Leukemia with Different Subtypes
    Zaker, Farhad
    Mohammadzadeh, Mohammad
    Mohammadi, Mohammad
    ARCHIVES OF IRANIAN MEDICINE, 2010, 13 (01) : 21 - 25
12345